MA
Michael A Metzger sold $785K of SNDX stock
Michael A Metzger, Chief Executive Officer of Syndax Pharmaceuticals Inc (SNDX), sold 32,375 shares of SNDX stock worth $785K, per an SEC Form 4 filed Jul 9, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Jul 8, 2026, 1 day before it was made public.
SNDX has moved -61.1% since the trade date, from $24.56 to $9.55 (Nov 9, 2026 close).
- Traded
- Jul 8, 2026
- Disclosed
- Jul 9, 2026
- Filing delay
- 1 day
- Price since
- -61.1%
- Role
- Chief Executive Officer
- Source
- SEC Form 4